- Home
- SKYE vs BROG Comparison
SKYE vs BROG Comparison
Compare SKYE & BROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- BROG
- Stock Information
- Founded
- SKYE 2012
- BROG 2019
- Country
- SKYE United States
- BROG United Arab Emirates
- Employees
- SKYE N/A
- BROG N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- BROG Integrated oil Companies
- Sector
- SKYE Health Care
- BROG Energy
- Exchange
- SKYE Nasdaq
- BROG Nasdaq
- Market Cap
- SKYE 108.3M
- BROG 114.0M
- IPO Year
- SKYE N/A
- BROG N/A
- Fundamental
- Price
- SKYE $3.84
- BROG $1.57
- Analyst Decision
- SKYE Buy
- BROG
- Analyst Count
- SKYE 6
- BROG 0
- Target Price
- SKYE $18.67
- BROG N/A
- AVG Volume (30 Days)
- SKYE 580.3K
- BROG 57.5K
- Earning Date
- SKYE 11-09-2024
- BROG 10-18-2024
- Dividend Yield
- SKYE N/A
- BROG N/A
- EPS Growth
- SKYE N/A
- BROG 174.67
- EPS
- SKYE N/A
- BROG 0.69
- Revenue
- SKYE N/A
- BROG $116,053,731.00
- Revenue This Year
- SKYE N/A
- BROG N/A
- Revenue Next Year
- SKYE N/A
- BROG N/A
- P/E Ratio
- SKYE N/A
- BROG $2.25
- Revenue Growth
- SKYE N/A
- BROG 161.86
- 52 Week Low
- SKYE $1.44
- BROG $0.80
- 52 Week High
- SKYE $19.41
- BROG $6.66
- Technical
- Relative Strength Index (RSI)
- SKYE 40.51
- BROG 58.94
- Support Level
- SKYE $3.40
- BROG $1.37
- Resistance Level
- SKYE $3.78
- BROG $1.64
- Average True Range (ATR)
- SKYE 0.54
- BROG 0.19
- MACD
- SKYE -0.04
- BROG -0.01
- Stochastic Oscillator
- SKYE 30.31
- BROG 56.46
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About BROG Brooge Energy Limited
Brooge Energy Ltd is an Oil Refinery & Storage Company in the United Arab Emirates. The company generates revenue from the leasing of storage capacity of tanks and other ancillary services.